The Financialization of Disruptive Technology
The Agile Manager
SEPTEMBER 30, 2019
A recent FT Lex article on biotech investing drives the point home: "A 20-year study found only one-fifth of exits were profitable. The whole point of the portfolio model applied to captive technology investing was to avoid taking a long position in any one thing. Investment yields are highly concentrated. Picking winners is hard.
45 
Let's personalize your content